Overexpression of miR-211 in melanoma cells induces their resistance to BRAF and MEK inhibitors, which is associated with an increase in the phosphorylated fraction of ERK5 effectors of a MAPK pathway other than BRAF. This evidence concerns the gene BRAF and melanoma.